Enliven Therapeutics, Inc. (ELVN) earnings date

Nasdaq · Mid cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 44 days, typically, give or take 13 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Thu, Nov 5, 2026after close 36 8-K
Q2 FY2026Wed, Aug 5, 2026after close 36 8-K
Q1 FY2026Thu, May 7, 2026after close 37 8-K
Q4 FY2025Tue, Mar 3, 2026after close 62 8-K
Q3 FY2025Wed, Nov 12, 2025after close 43 8-K
Q2 FY2025Wed, Aug 13, 2025after close 44 8-K
Q1 FY2025Wed, May 14, 2025after close 44 8-K
Q4 FY2024Thu, Mar 13, 2025after close 72 8-K

What they guided beta

Q3 FY2026 "Exhibit 99.1 Enliven Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Business Update Reached alignment with the FDA on the final design of the ENABLE-2 pivotal Phase 3 trial On track to initiate ENABLE-2 before year-end 2026" exhibit
Q3 FY2026 "Strong balance sheet with $884 million in cash, cash equivalents and marketable securities, which is expected to provide cash runway into 2030 BURLINGAME, Calif., Nov. 5, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today reported financial results for the third quarter ended September 30, 2026, and provided a business update." exhibit
Q3 FY2026 "The Company remains on track to initiate ENABLE-2 before year-end 2026." exhibit
Q3 FY2026 "Cash position: As of September 30, 2026, the Company had cash, cash equivalents and marketable securities totaling $884.4 million, which is expected to provide cash runway into 2030." exhibit
Q2 FY2026 "efficacy data and a favorable safety and tolerability profile Reached alignment with the FDA on key Phase 3 trial design components Strong balance sheet with $895 million in cash, cash equivalents and marketable securities, which is expected to provide cash runway into 2030 BURLINGAME, Calif., Aug. 5, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today reported financial results for the second quarter ended June 30, 2026, and provided" exhibit
Q2 FY2026 "Key outcomes from the End-of-Phase 1 meeting with the U.S. Food and Drug Administration (FDA): o 80 mg QD selected as the recommended dose for Phase 3 ENABLE-2 trial. o ENABLE-2 is expected to enroll patients with CML previously treated with one or more TKIs, and to be randomized to receive either ELVN-001 or physician's choice of an ATP-competitive TKI. o Additional details of the Phase 3 trial design are expected to be finalized following further discussions with the FDA, including at a planned End-of-Phase 2 meeting anticipated in the third quarter of 2026." exhibit
Q2 FY2026 "Collectively, these data and regulatory milestones continue to support advancement of ELVN-001 into the planned ENABLE-2 Phase 3 trial, which the Company expects to initiate in the second half of 2026." exhibit
Q2 FY2026 "Cash position: As of June 30, 2026, the Company had cash, cash equivalents and marketable securities totaling $895.2 million, which is expected to provide cash runway into 2030." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/ELVN
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/ELVN

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

ELVN earnings date badge

HTML

<a href="https://veritasdata.dev/company/ELVN/"><img src="https://veritasdata.dev/embed/ELVN.svg" alt="ELVN earnings date" width="240" height="56"></a>

Markdown

[![ELVN earnings date](https://veritasdata.dev/embed/ELVN.svg)](https://veritasdata.dev/company/ELVN/)

Script

<script async src="https://veritasdata.dev/embed/ELVN.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/ELVN"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.